DIABETIC MACULAR EDEMA

This study tested the safety of aflibercept eye injections for diabetic macular edema (DME) in Indian patients. DME is a diabetes complication where fluid leaks into the retina, causing vision loss. Researchers followed 100 participants for one year, giving regular injections and…

This study compared two types of eye injections given one week before cataract surgery in diabetic patients who already had eye swelling. Researchers wanted to see which injection (anti-VEGF drugs like Avastin or Lucentis versus the steroid Ozurdex) better controlled swelling aft…

This study checked how much of a high-dose eye medication gets into the bloodstream when injected into both eyes. Researchers gave 51 adults with diabetic macular edema or age-related macular degeneration injections in both eyes and measured drug levels in their blood. The goal w…

This study tested an oral medication called RZ402 for diabetic macular edema, a common cause of vision loss in people with diabetes. 94 participants with mild to moderate eye changes were randomly assigned to receive either RZ402 or a placebo pill for 12 weeks. Researchers measur…

This study tested whether a drug called PRO-169 works as well as the standard treatment, Lucentis (ranibizumab), for diabetic macular edema—a common cause of vision loss in people with diabetes. Over 500 adults received monthly eye injections of one of the two drugs for a year, w…

This study aimed to test a new way to treat diabetic macular edema, a swelling in the eye that can cause vision loss. It compared two doses of a long-acting steroid medicine delivered by a special illuminated catheter against a standard steroid implant. The trial was stopped earl…

This study tested a new eye injection called AG-73305 in people with diabetic macular edema, a condition where diabetes causes fluid buildup in the eye that can damage vision. Researchers gave 25 participants different doses of the injection to check if it was safe and if it help…

This study tested whether adding a new drug called vamikibart to a standard eye injection (ranibizumab) works better for diabetic macular edema (DME) than the standard injection alone. DME is a swelling in the back of the eye that can cause vision loss in people with diabetes. Th…

This study tested a new medication called vamikibart, given as an injection into the eye, for people with diabetic macular edema (DME), a condition that causes vision loss. It compared the new injection to an existing treatment to see if it was better at improving or preserving e…

This study followed patients who had already completed earlier trials of faricimab, a medication injected into the eye to treat diabetic macular edema (swelling in the back of the eye). Researchers monitored 1,479 patients for long-term side effects, particularly looking for any …

This study aimed to find out if specific patterns seen on standard eye scans could predict how well a patient with diabetic macular edema (DME) would respond to treatment. Researchers observed 32 patients with DME, analyzing their routine eye imaging to see if certain scan featur…

This study measured the thickness of eye tissues in people with two common vision conditions (neovascular age-related macular degeneration and diabetic macular edema) and compared them to healthy people. Researchers used a special imaging machine to take detailed pictures of the …